MITF and neoplasm: Low MITF levels are associated with invasive (Carreira et al., 2006), tumor‐initiating (Cheli, Guiliano, et al., 2011b), and drug‐ and immunotherapy‐resistant phenotypes (Dugo et al., 2015; Konieczkowski et al., 2014; Landsberg et al., 2012; Muller et al., 2014; Riesenberg et al., 2015; Tirosh et al., 2016).